Research facility · founded 1983
Beckman Research Institute
- Citations, last 5 years
- 43.4k
- Works, last 5 years
- 2 597
- h-index
- 528
- Scientists listed
- 25
- Grants since 2016
- 719
Grants received
2019 · research · R01
Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation with Movement to Improve Prognosis in Breast Cancer Survivors
Christina Dieli-Conwright · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
The role of O-GlcNAcylation in DNA damage repair and cancer therapy
Jeremy Michael Stark · Beckman Research Institute · funded by National Institutes of Health
2019–2025 · research · R01
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer
Ajay Goel · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
DNA repair gene mutations and prostate cancer
Binghui Shen · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
(PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research
Shiuan Chen · Beckman Research Institute · funded by National Institutes of Health
2019–2020 · research · R01
Osteoprotegerin and the Pancreatic Beta Cell
Rupangi C Vasavada · Beckman Research Institute · funded by National Institutes of Health
2019–2023 · program · P20
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
Ernest Martinez · Beckman Research Institute · funded by National Institutes of Health
2019–2022 · research · R21
Altering Intake and Managing Symptoms in Rectal Cancer Survivors: A Multimodal Diet Modification Intervention for Bowel Dysfunction
Virginia Chih-Yi Sun · Beckman Research Institute · funded by National Institutes of Health
2019–2026 · grant · OT3
CureSC Manufacturing Resource Platform
Angelo A. Cardoso · Beckman Research Institute · funded by National Institutes of Health
2019–2022 · research · R01
Bone Marrow Niche dysfunction in sickle cell disease
Nadia Carlesso · Beckman Research Institute · funded by National Institutes of Health
2019–2020 · award
Image-based Biomarker to Differentiate Tumor Progression from Tumor Necrosis and Pseudoprogression after Radiation Therapy for Lung Cancer
Arya Amini · Beckman Research Institute · funded by American Cancer Society
2019–2024 · research · R01
Regulation of N6-methyladenosine (m6A) deposition by arginine methylation
Yanzhong Yang · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
RECQ5-dependent SUMO2 conjugation of PCNA in the resolution of transcription-replication conflicts
Yilun Liu · Beckman Research Institute · funded by National Institutes of Health
2019–2021 · research · R03
Patient-Defined Goals and Preferences Among Older Adults with Advanced Neuroendocrine Tumors
Daneng Li · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
RECQ5-dependent SUMO2 conjugation of PCNA in the resolution of transcription-replication conflicts
Yilun Liu · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of N6-methyladenosine (m6A) deposition by arginine methylation
Yanzhong Yang · Beckman Research Institute · funded by National Institutes of Health
2019–2021 · research · R03
Characterization of CEACAM1 as a novel therapeutic in mantle cell lymphoma
Vu Nguyen Ngo · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer
Peter Poon-Hang Lee · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Role of BAZ2A in MLL-r leukemia and therapeutic response
Chun-Wei David Chen · Beckman Research Institute · funded by National Institutes of Health
2019–2025 · research · R01
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
Behnam Badie · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of N6-methyladenosine (m6A) deposition by arginine methylation
Yanzhong Yang · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
(PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research
Shiuan Chen · Beckman Research Institute · funded by National Institutes of Health
2019–2022 · research · R21
scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid Leukemia
Jianhua Yu · Beckman Research Institute · funded by National Institutes of Health
2019–2023 · grant · OT3
CureSC Manufacturing Resource Platform
Angelo A. Cardoso · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Exploring the preclinical relevance of therapeutic radiolabeled daratumumab (anti-CD38) in combination with anti-CS1 CAR T cells as a novel combinatorial treatment for multiple myeloma
Flavia Pichiorri · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Role of BAZ2A in MLL-r leukemia and therapeutic response
Chun-Wei David Chen · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML
Jianjun Chen · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
Christiane Querfeld · Beckman Research Institute · funded by National Institutes of Health
2019–2021 · research · R21
Altering Intake and Managing Symptoms in Rectal Cancer Survivors: A Multimodal Diet Modification Intervention for Bowel Dysfunction
Virginia Chih-Yi Sun · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells
Jianhua Yu · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer
Peter Poon-Hang Lee · Beckman Research Institute · funded by National Institutes of Health
2019–2025 · research · R01
Regulating SNARE mechanisms to remediate glucose homeostasis
Debbie C Thurmond · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer
Ajay Goel · Beckman Research Institute · funded by National Institutes of Health
2019–2026 · grant · OT3
CureSC Manufacturing Resource Platform
Angelo A. Cardoso · Beckman Research Institute · funded by National Institutes of Health
2019–2022 · research · R01
Bone Marrow Niche dysfunction in sickle cell disease
Nadia Carlesso · Beckman Research Institute · funded by National Institutes of Health
2019–2026 · grant · OT3
CureSC Manufacturing Resource Platform
Angelo A. Cardoso · Beckman Research Institute · funded by National Institutes of Health
2019–2022 · research · R01
Integrative Analyses of Saturation CRISPR Protein Scan
Chun-Wei David Chen · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer
Ajay Goel · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells
Jianhua Yu · Beckman Research Institute · funded by National Institutes of Health
2019–2024 · research · R01
Role of BAZ2A in MLL-r leukemia and therapeutic response
Chun-Wei David Chen · Beckman Research Institute · funded by National Institutes of Health